Core Viewpoint - Celanese Corporation is facing significant financial challenges due to weak demand in key markets, leading to substantial stock price declines and potential legal investigations regarding securities fraud [1][3][4][5]. Financial Performance - In Q3 2024, Celanese reported adjusted earnings of $2.44 per share, below the consensus estimate of $2.84 per share, with revenue of $2.65 billion, a 2.6% year-over-year decline, and also below the consensus estimate of $2.69 billion [3]. - For the full year 2024, Celanese reported a U.S. GAAP diluted loss per share of $13.86 and adjusted earnings per share of $8.37, with net sales of $10.3 billion, a 6% decrease from the previous year due to a 4% decline in price and a 1% decline in volume [4]. - In Q2 2025, Celanese reported continued low volumes in its Engineered Materials segment, indicating ongoing challenges in demand [5]. Stock Price Reaction - Following the Q3 2024 results, Celanese's stock price fell by $32.50, or 26.32%, closing at $91.00 per share [3]. - After the Q4 and full year 2024 results, the stock price dropped by $15.00, or 21.46%, closing at $54.91 per share [4]. - On disappointing Q2 2025 results, the stock price decreased by $6.20, or 13.07%, closing at $41.22 per share [5]. Legal Investigation - Pomerantz LLP is investigating claims on behalf of investors regarding potential securities fraud or unlawful business practices by Celanese and its officers/directors [1].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celanese Corporation - CE